How is age-related macular degeneration diagnosed? Which patient is at risk of the disease? What are the treatment options? These, in short, are the questions to which some of the most authoritative have been asked to answerspecialists in ophthalmology, during the webinar recently held within the training course of Floretina 2021, on the topic ‘Neovascular Amd in real life’, chaired by Edoardo Midena, professor of Diseases of the visual apparatus and director of the School of Specialization in Ophthalmology of the University of Padua, and by Stanislao Rizzo, director of the Ophthalmology complex operating unit of the A. Gemelli Irccs University Hospital of Rome, organized with the unconditional contribution of Bayer.
Read Also
- Paola Di Bendetto: the social joke Aug 28, 2021
- Russian troops have attacked nearly 1,900 Ukrainian schools since the beginning of the invasion. Jun 3, 2022
- Charlene of Monaco is hidden : his message enthusiastic with the prince Albert Jun 4, 2020
- OppFi says CFPB staff is not recommending enforcement action Aug 31, 2021
- “I don’t like him”: Yordi Rosado revealed the conflicts he had with Christina Aguilera Oct 7, 2020
- COVID-19 in Exatlón México ?: Toño Rosique clarified how the production is Sep 21, 2020
- Gen Z consumes the most anime, survey reveals Jul 15, 2021